GIVXF yields 186.13% · PFE yields 6.13%● Live data
📍 GIVXF pulled ahead of the other in Year 1
Combined, GIVXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GIVXF + PFE for your $10,000?
Givex Information Technology Group Limited provides omni-channel gift cards, loyalty programs, data analytics, stored value tickets, payment processing, and cloud-based Point of Sale (POS) solutions in Canada, the United States, Australia, the United Kingdom, and internationally. It offers gift card processing, gift card production and fulfillment, mobile wallet solutions, and personalized cards; POS systems; analytics solutions; Uptix, a ticketing solution; self-ordering kiosks; and GivexPay, a payment solution. The company also operates CWS, an interactive gift card Website; loyalty programs; and Givex Go, a mobile application. In addition, it offers recycled PVC cards, PLA cards, paper stock cards, soy-based inks for gift card carriers, recycled material for gift card carriers, and shredding and recycling of deactivated cards. The company was founded in 1999 and is headquartered in Toronto, Canada.
Full GIVXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.